Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
Is a |
morphinsulfat + atropinsulfat |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Morphine (substance) |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Atropine (substance) |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Morphine sulfate |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phenanthrene derivative (substance) |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
Is a |
Product containing morphine in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
Is a |
Atropine-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Atropine sulfate |
false |
Inferred relationship |
Some |
|
|